Delivery Order 36F79720D0017-36C26123N0288
Award Date 12/16/22
Potential Completion Date 6/12/23
Potential Value $74K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $18,030.08 delivery order to Dompe U.S. Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB). The delivery order is for OXERVATE PHARMACUETICAL products to support the VA's healthcare programs. Performance will take place in Bartlett, Tennessee, with an expected completion date of February 27, 2022. No set-aside designation was used for this award...
- <p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $124,955.44 delivery order to Dompe U.S. Inc. against the Pharmaceuticals and Drugs Federal Supply Schedule contract. The firm fixed price order is for the product OXERVATE to be delivered to a location in Boston, Massachusetts by September 30, 2021. No set-aside designation was used for this award to support the VA's healthcare programs for veterans in the region.</p>
- The Department of Veterans Affairs Veterans Health Administration awarded a $149,388 firm fixed price delivery order against GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB) to Dompe U.S. Inc. for OXERVATE 0.002% solution. Performance will take place in Bartlett, Tennessee over approximately two months concluding in late September 2023. As part of its mission to provide healthcare services to veterans, VA-VHA Network 5 will utilize this contract to procure an ophthalmic solution from the prime...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $18,030.08 delivery order to Dompe U.s. Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The firm fixed price order is for the delivery of OXERVATE 0.002% solution, initially for a two week period, with performance taking place in San Mateo, California. No set-aside designation was applied to this award made on February 15, 2022 for pharmaceutical...
- This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to Dompe U.S. Inc. for the provision of OXERVATE 0.002% ophthalmic solution. With a potential value of $17,728.60 and a completion date of January 5, 2022, this firm fixed price order is for the delivery of the specified pharmaceutical to support care provided by VISN 20, which serves veterans...
- This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule, awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20, is for $72,120.32 of OXERVATE 0.002% ophthalmic solution. The prime contractor is Dompe U.S. Inc. located in San Mateo, California, where the place of performance will be. The completion date is December 20, 2022. No set-aside designation was used for this contract. The pricing is firm fixed...
- This is a firm fixed price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Dompe U.S. Inc., a foreign-owned pharmaceutical manufacturer, under the General Services Administration (GSA) Pharmaceuticals and Drugs schedule contract (FSS-61-IB). The order is for the supply of Oxervate, an ophthalmic solution used to treat neurotrophic keratitis, to VA facilities across the country. The delivery order has a ceiling value of $38,614.40 and a period of performance ending on...
- This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to Dompe U.S. Inc. for the provision of OXERVATE 0.002% ophthalmic solution. With a potential value of $70,344.24 and a completion date of October 10, 2020, this firm fixed price contract calls for Dompe U.S. Inc. to deliver the specified pharmaceutical product to locations within Boston,...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) to Dompe U.S. Inc., a foreign-owned, for-profit pharmaceutical manufacturer, against the General Services Administration (GSA) Pharmaceuticals and Drugs schedule (FSS-61-IB). The $19,887.06 firm fixed price order is for the supply of Oxervate, an ophthalmic solution used to treat neurotrophic keratitis. This award is not set-aside and is part of a larger $2.4 million blanket purchase agreement Dompe holds with the VA...
- This is a delivery order contract awarded to Dompe U.S. Inc., a foreign-owned, for-profit pharmaceutical manufacturer, by the Department of Veterans Affairs (VA). The contract is for the provision of Oxervate, an ophthalmic solution used to treat neurotrophic keratitis, to VA facilities across the country. The contract is a firm fixed-price order placed against the General Services Administration (GSA) Pharmaceuticals and Drugs schedule (FSS-61-IB). The contract has a ceiling value of $19,887.06...